Off the wire
• Australian state facing biggest severe bushfire risk in history: scientist  • Heatwaves occurring earlier and more often in Australia: climate report  • Banks help lift Australian market in morning trade  • Tokyo stocks open higher on strong showing of Wall Street  • Australian dollar dips  • Dollar changes hands in lower 112 yen range in early trade in Tokyo  • Xinhua world news summary at 0030 GMT, Feb. 8  • Chapecoense air crash survivor Neto returns to training  • Son of Brazil great Rivaldo joins Dinamo Bucharest  • Colombia striker Borja close to Palmeiras deal  
You are here: 　 Home/ Government Policy

China issues guideline on vaccine development, management

Xinhua, February 8, 2017 Adjust font size:

The central government has issued a guideline to boost development and management of vaccines.

The guideline, issued by the General Office of the State Council, called for support in vaccine research and development and efforts to improve vaccine quality.

Vaccine manufacturers should be encouraged to upgrade their management of vaccine quality and production, according to the document.

The guideline also called for enhanced supervision of purchases and distribution of vaccines.

Procurement of vaccines should be made online in a transparent and fair manner, and production, purchase and distribution of vaccines should be well tracked, it said.

A scandal broke in March 2016 when improperly stored vaccines were found to have been sold to patients.

Following the scandal, China has carried out a series of measures to fix loopholes in distribution.